SCHEMBL18178693

SCHEMBL18178693

CCC(=O)Oc1cccc(Br)c1COc1cc(C)c(C)cc1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 4/20 0.38
ACHE P22303 1/20 0.37
ACLY P53396 1/20 0.35
SLC22A12 Q96S37 1/20 0.34
PTGER1 P34995 2/20 0.34
GUCY1B2 O75343 2/20 0.34
GUCY1A2 P33402 2/20 0.34
GUCY1A1 Q02108 2/20 0.34
GUCY1B1 Q02153 2/20 0.34
PTGFR P43088 1/20 0.34
LMNA P02545 2/20 0.33
GAA P10253 2/20 0.33
KMT2A Q03164 2/20 0.33
KDM4E B2RXH2 1/20 0.33
GLA P06280 1/20 0.33
HPGD P15428 1/20 0.33
MAPK1 P28482 1/20 0.33
HSD17B10 Q99714 1/20 0.33
ATM Q13315 1/20 0.33
FFAR4 Q5NUL3 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18178547 0.94 MRGPRX4 (0.40) MRGPRX4ACHEACLYSLC22A12PTGER1
SCHEMBL18182801 0.92 FFAR4 (0.35) MRGPRX4ACHEACLYSLC22A12PTGER1
SCHEMBL18178642 0.91 MAPT (0.36) MRGPRX4ACHEPTGER1LMNAALDH1A1
SCHEMBL18178709 0.89 SLC22A12 (0.41) MRGPRX4ACHEACLYSLC22A12GUCY1B2
SCHEMBL18178706 0.89 MRGPRX4 (0.40) MRGPRX4ACHEACLYSLC22A12PTGER1
SCHEMBL18178754 0.89 MAPT (0.40) MRGPRX4ACHESLC22A12LMNAGAA
SCHEMBL18178725 0.89 ACHE (0.39) MRGPRX4ACHESLC22A12LMNAGAA
SCHEMBL18178341 0.88 MRGPRX4 (0.38) MRGPRX4SLC22A12PTGER1GUCY1B2GUCY1A2
SCHEMBL18178447 0.87 MRGPRX4 (0.49) MRGPRX4ACHEPTGER1PTGFRLMNA
SCHEMBL18178562 0.87 MRGPRX4 (0.37) MRGPRX4ACHEACLYSLC22A12PTGER1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9573904-B2 Aromatic compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-02-21 US disclosed
US-20160311775-A1 AROMATIC COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160311775-A1 AROMATIC COMPOUND AND USE THEREOF ZCCHC8, CBR3, CBX8 MRGPRX4 167/4885ACHE 460/4885ACLY 1774/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.